Cover Image
市場調查報告書

運動醫學的全球市場:趨勢·預測

Global Sports Medicine Market - Industry Trends and Forecast to 2024

出版商 Data Bridge Market Research Private Limited 商品編碼 536509
出版日期 內容資訊 英文 415 Pages; 295 Tables; 58 Figures
商品交期: 最快1-2個工作天內
價格
Back to Top
運動醫學的全球市場:趨勢·預測 Global Sports Medicine Market - Industry Trends and Forecast to 2024
出版日期: 2017年07月01日 內容資訊: 英文 415 Pages; 295 Tables; 58 Figures
簡介

本報告提供全球運動醫學的市場調查,提供市場定義和概要,市場的各種影響因素及市場機會分析,產品類型·部位·終端用戶·地區/各主要國家趨勢與市場規模的變化與預測,競爭環境,並彙整主要企業的簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 市場概要

  • 概要
  • 成長推進因素
  • 阻礙成長要素
  • 市場機會
  • 課題

第4章 重要考察

第5章 摘要整理

第6章 市場分析:各產品類型

  • 概要
  • 生物性骨材:各產品類型
    • 替代骨移植片
    • 關節內補充藥
    • 濃縮骨髓穿刺液 (BMC)
    • 多血小板血漿 (PRP)
  • 外科用設備:各產品類型
  • 關節鏡檢查設備:各產品類型
  • 整形外科用矯正器&支援:各產品類型

第7章 市場分析:各部位

  • 概要
  • 髖關節
  • 肩膀·肘
  • 腳·腳踝
  • 手·手腕

第8章 關節鏡檢查設備市場:各治療

  • 概要
  • 膝關節鏡手術
  • 髖關節關節鏡手術
  • 肩膀·肘關節鏡手術
  • 腳·腳踝關節鏡手術
  • 手·手腕關節鏡手術

第9章 市場分析:各終端用戶

  • 概要
  • 醫院
  • 整形外科診所
  • 門診外科中心
  • 其他

第10章 地區分析

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 土耳其
    • 比利時
    • 荷蘭
    • 瑞士
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 韓國
    • 印度
    • 澳洲
    • 新加坡
    • 泰國
    • 馬來西亞
    • 印尼
    • 菲律賓
    • 其他
  • 南美
    • 巴西
    • 其他
  • 中東·非洲
    • 南非
    • 其他

第11章 競爭環境

  • 企業佔有率分析

第12章 企業簡介

第13章 附錄

目錄

Synopsis:

Global Sports Medicine Market is expected to reach USD 34.7 billion by 2024, at a CAGR of 8.9% during the forecast period of 2017 to 2024. The report contains 416 pages of exclusive premium insights with 295 tables and 58 figures.

Global Sports Medicine Market is segmented based on product type, body area, type, end-user, and geography.

On the basis of product type the market is segmented into orthobiologics, surgical devices, arthroscopy devices and orthopedic braces and supports.

The market is also segmented on body area into knee, hip, shoulder and elbow, foot and ankle and, hand and wrist. On the basis of distribution channel, the market is segmented into direct tenders and retail.

The market is segmented based on end-user into hospitals, orthopedic clinics, ambulatory surgical centers and others.

The global sports medicine market is segmented into 5 regions such as North America, Europe, Asia-Pacific, South America and Middle East and Africa.

Major Players Operating in this market:

Arthrex, Inc., Smith and Nephew, Medtronic, Stryker, Conmed Corporation, Zimmer, Inc., DJO Global, Ossur Corporate, Ottobock Healthcare GmbH, Breg, Inc., Tornier, Inc., Mueller Sports Medicine, Inc., Cramer Products, Inc., RTI Surgical, ArthroCare, Biomet, Bird and Cronin, Inc., Cayenne Medical, Inc., DePuyMitek, Inc., Ossur and many others.

Regions Covered In The Scope Of The Report:

Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America), Middle East and Africa( South Africa, Rest of MEA)).

Table of Contents

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
  • 1.4. OVERVIEW OF GLOBAL SPORTS MEDICINE MARKET
  • 1.5. CURRENCY AND PRICING
  • 1.6. LIMITATION
  • 1.7. MARKETS COVERED

2. RESEARCH METHODOLOGY

  • 2.1. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.2. SECONDARY SOURCES
  • 2.3. ASSUMPTIONS

3. MARKET OVERVIEW

  • 3.1. OVERVIEW
  • 3.2. DRIVERS
    • 3.2.1. INCREASING INCIDENCES OF SPORTS INJURIES
    • 3.2.2. INCREASING ADOPTION OF ARTHROSCOPIC SURGERIES
    • 3.2.3. CONTINUOUS INFLUX OF NEW PRODUCTS AND TREATMENT MODALITIES
    • 3.2.4. GROWING RESEARCH ACTIVITIES IN SPORTS MEDICINE
    • 3.2.5. DEVELOPMENTS IN THE FIELD OF REGENERATIVE MEDICINE
    • 3.2.6. INCREASED ADOPTION AND ACCEPTANCE OF ARTHROSCOPY & MINIMALLY INVASIVE PROCEDURES
  • 3.3. RESTRAINTS
    • 3.3.1. HIGH COST OF IMPLANTS AND OTHER DEVICES
    • 3.3.2. MEDICAL DEVICES EXCISE TAX IN THE U.S.
  • 3.4. OPPORTUNITIES
    • 3.4.1. GENERIC IMPLANTS
    • 3.4.2. EXPANSION AND MARKET PENETRATION OPPORTUNITIES IN EMERGING ECONOMIES
  • 3.5. CHALLENGES
    • 3.5.1. LACK OF TRAINED PROFESSIONALS

4. PREMIUM INSIGHTS

5. EXECUTIVE SUMMARY

  • 5.1. KEY MARKET DRIVERS
  • 5.2. MARKET SEGMENTATION

6. GLOBAL SPORTS MEDICINE MARKET, BY PRODUCT TYPE

  • 6.1. OVERVIEW
  • 6.2. GLOBAL ORTHOBIOLOGICS MARKET, BY PRODUCT TYPE
    • 6.2.1. BONE GRAFT SUBSTITUTE
    • 6.2.2. VISCOSUPPLEMENTATION
    • 6.2.3. BONE MARROW CONCENTRATE (BMC)
    • 6.2.4. PLATELET RICH PLASMA (PRP)
  • 6.3. GLOBAL SURGICAL DEVICES MARKET, BY PRODUCT TYPE
  • 6.4. GLOBAL ARTHROSCOPY DEVICES MARKET, BY PRODUCT TYPE
  • 6.5. GLOBAL ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT TYPE

7. GLOBAL SPORTS MEDICINE MARKET, BY BODY AREA

  • 7.1. OVERVIEW
  • 7.2. KNEE
  • 7.3. HIP
  • 7.4. SHOULDER AND ELBOW
  • 7.5. FOOT AND ANKLE
  • 7.6. HAND AND WRIST

8. GLOBAL ARTHROSCOPY DEVICES MARKET, BY PROCEDURE

  • 8.1. OVERVIEW
  • 8.2. KNEE ARTHROSCOPIC PROCEDURES
  • 8.3. HIP ARTHROSCOPIC SURGERIES
  • 8.4. SHOULDER AND ELBOW ARTHROSCOPIC PROCEDURES
  • 8.5. FOOT AND ANKLE ARTHROSCOPIC PROCEDURES
  • 8.6. HAND AND WRIST ARTHROSCOPIC PROCEDURES

9. GLOBAL SPORTS MEDICINE MARKET, BY END USER

  • 9.1. OVERVIEW
  • 9.2. HOSPITALS
  • 9.3. ORTHOPEDIC CLINICS
  • 9.4. AMBULATORY SURGICAL CENTERS
  • 9.5. OTHERS

10. GLOBAL SPORTS MEDICINE MARKET, BY GEOGRAPHY

  • 10.1. OVERVIEW
  • 10.2. NORTH AMERICA SPORTS MEDICINE MARKET, BY GEOGRAPHY
    • 10.2.1. U.S. SPORTS MEDICINE MARKET
    • 10.2.2. CANADA SPORTS MEDICINE MARKET
    • 10.2.3. MEXICO SPORTS MEDICINE MARKET
  • 10.3. EUROPE SPORTS MEDICINE MARKET, BY COUNTRY
    • 10.3.1. OVERVIEW
    • 10.3.2. GERMANY SPORTS MEDICINE MARKET
    • 10.3.3. FRANCE SPORTS MEDICINE MARKET
    • 10.3.4. U.K. SPORTS MEDICINE MARKET
    • 10.3.5. ITALY SPORTS MEDICINE MARKET
    • 10.3.6. SPAIN SPORTS MEDICINE MARKET
    • 10.3.7. RUSSIA SPORTS MEDICINE MARKET
    • 10.3.8. TURKEY SPORTS MEDICINE MARKET
    • 10.3.9. BELGIUM SPORTS MEDICINE MARKET
    • 10.3.10. NETHERLANDS SPORTS MEDICINE MARKET
    • 10.3.11. SWITZERLAND SPORTS MEDICINE MARKET
    • 10.3.12. REST OF EUROPE SPORTS MEDICINE MARKET
  • 10.4. APAC SPORTS MEDICINE MARKET, BY GEOGRAPHY
    • 10.4.1. OVERVIEW
    • 10.4.2. JAPAN SPORTS MEDICINE MARKET, BY GEOGRAPHY
    • 10.4.3. CHINA SPORTS MEDICINE MARKET, BY GEOGRAPHY
    • 10.4.4. SOUTH KOREA SPORTS MEDICINE MARKET,BY GEOGRAPHY
    • 10.4.5. INDIA SPORTS MEDICINE MARKET, BY GEOGRAPHY
    • 10.4.6. AUSTRALIA SPORTS MEDICINE MARKET, BY GEOGRAPHY
    • 10.4.7. SINGAPORE SPORTS MEDICINE MARKET, BY GEOGRAPHY
    • 10.4.8. THAILAND SPORTS MEDICINE MARKET, BY GEOGRAPHY
    • 10.4.9. MALAYSIA SPORTS MEDICINE MARKET, BY GEOGRAPHY
    • 10.4.10. INDONESIA SPORTS MEDICINE MARKET, BY GEOGRAPHY
    • 10.4.11. PHILIPPINES SPORTS MEDICINE MARKET, BY GEOGRAPHY
    • 10.4.12. REST OF APAC SPORTS MEDICINE MARKET
  • 10.5. SOUTH AMERICA SPORTS MEDICINE MARKET, BY GEOGRAPHY
    • 10.5.1. OVERVIEW
    • 10.5.2. BRAZIL SPORTS MEDICINE MARKET
    • 10.5.3. REST OF SOUTH AMERICA SPORTS MEDICINE MARKET
  • 10.6. MEA SPORTS MEDICINE MARKET, BY GEOGRAPHY
    • 10.6.1. OVERVIEW
    • 10.6.2. SOUTH AFRICA SPORTS MEDICINE MARKET
    • 10.6.3. REST OF MEA SPORTS MEDICINE MARKET

11. GLOBAL SPORTS MEDICINE MARKET, COMPANY LANDSCAPE

  • 11.1. COMPANY SHARE ANALYSIS: GLOBAL

12. COMPANY PROFILES

  • 12.1. SMITH & NEPHEW
    • 12.1.1. COMPANY OVERVIEW
    • 12.1.2. SWOT ANALYSIS
      • 12.1.2.1. DRIVERS EXPLAINED
      • 12.1.2.2. WEAKNESS EXPLAINED
      • 12.1.2.3. OPPORTUNITIES EXPLAINED
      • 12.1.2.4. THREATS EXPLAINED
    • 12.1.3. SMITH & NEPHEW: REVENUE ANALYSIS
    • 12.1.4. PRODUCT PORTFOLIO
    • 12.1.5. RECENT DEVELOPMENTS
  • 12.2. CONMED CORPORATION
    • 12.2.1. COMPANY OVERVIEW
    • 12.2.2. SWOT ANALYSIS
      • 12.2.2.1. DRIVERS EXPLAINED
      • 12.2.2.2. WEAKNESS EXPLAINED
      • 12.2.2.3. OPPORTUNITIES EXPLAINED
      • 12.2.2.4. THREATS EXPLAINED
    • 12.2.3. CONMED CORPORATION:REVENUE ANALYSIS
    • 12.2.4. PRODUCT PORTFOLIO
    • 12.2.5. RECENT DEVELOPMENTS
  • 12.3. JOHNSON& JOHNSON SERVICES, INC. (MITEK IS A SUBSIDIARY)
    • 12.3.1. COMPANY OVERVIEW
    • 12.3.2. SWOT ANALYSIS
      • 12.3.2.1. DRIVERS EXPLAINED
      • 12.3.2.2. WEAKNESSES EXPLAINED
      • 12.3.2.3. OPPORTUNITIES EXPLAINED
      • 12.3.2.4. THREATS EXPLAINED
    • 12.3.3. JOHNSON& JOHNSON SERVICES, INC.:REVENUE ANALYSIS
    • 12.3.4. PRODUCT PORTFOLIO
    • 12.3.5. RECENT DEVELOPMENTS
  • 12.4. ARTHREX, INC.
    • 12.4.1. COMPANY OVERVIEW
    • 12.4.2. ARTHREX, INC. : SNAPSHOT
    • 12.4.3. PRODUCT PORTFOLIO
    • 12.4.4. RECENT DEVELOPMENTS
  • 12.5. RTI SURGICALS, INC.
    • 12.5.1. COMPANY OVERVIEW
    • 12.5.2. RTI SURGICALS, INC.: REVENUE ANALYSIS
    • 12.5.3. PRODUCT PORTFOLIO
    • 12.5.4. RECENT DEVELOPMENTS
  • 12.6. BIRD & CRONIN, INC.
    • 12.6.1. COMPANY OVERVIEW
    • 12.6.2. BIRD & CRONIN, INC. : SNAPSHOT
    • 12.6.3. PRODUCT PORTFOLIO
    • 12.6.4. RECENT DEVELOPMENTS
  • 12.7. CRAMER PRODUCTS, INC.
    • 12.7.1. COMPANY OVERVIEW
    • 12.7.2. CRAMER PRODUCTS, INC.: SNAPSHOT
    • 12.7.3. PRODUCT PORTFOLIO
    • 12.7.4. RECENT DEVELOPMENTS
  • 12.8. ZIMMER BIOMET
    • 12.8.1. COMPANY OVERVIEW
    • 12.8.2. SWOT ANALYSIS
      • 12.8.2.1. DRIVERS EXPLAINED
      • 12.8.2.2. WEAKNESSES EXPLAINED
      • 12.8.2.3. OPPORTUNITIES EXPLAINED
      • 12.8.2.4. THREATS EXPLAINED
    • 12.8.3. PRODUCT PORTFOLIO
    • 12.8.4. RECENT DEVELOPMENTS
  • 12.9. ANIKA THERAPEUTICS, INC.
    • 12.9.1. COMPANY OVERVIEW
    • 12.9.2. PRODUCT PORTFOLIO
    • 12.9.3. RECENT DEVELOPMENTS
  • 12.10. OSSUR
    • 12.10.1. COMPANY OVERVIEW
    • 12.10.2. PRODUCT PORTFOLIO
    • 12.10.3. RECENT DEVELOPMENTS
  • 12.11. BREG, INC.
    • 12.11.1. COMPANY OVERVIEW
    • 12.11.2. PRODUCT PORTFOLIO
    • 12.11.3. RECENT DEVELOPMENTS
  • 12.12. MUELLER SPORTS MEDICINE, INC.
    • 12.12.1. COMPANY OVERVIEW
    • 12.12.2. PRODUCT PORTFOLIO
    • 12.12.3. RECENT DEVELOPMENTS
  • 12.13. DJO GLOBAL
    • 12.13.1. COMPANY OVERVIEW
    • 12.13.2. PRODUCT PORTFOLIO
  • 12.14. STRYKER CORPORATION
    • 12.14.1. COMPANY OVERVIEW
    • 12.14.2. SWOT ANALYSIS
    • 12.14.3. DRIVERS EXPLAINED
      • 12.14.3.1. WEAKNESSES EXPLAINED
      • 12.14.3.2. OPPORTUNITIES EXPLAINED
      • 12.14.3.3. THREATS EXPLAINED
    • 12.14.4. PRODUCT PORTFOLIO
    • 12.14.5. RECENT DEVELOPMENTS
  • 12.15. MEDTRONIC
    • 12.15.1. COMPANY OVERVIEW
    • 12.15.2. MEDTRONIC :REVENUE ANALYSIS
    • 12.15.3. PRODUCT PORTFOLIO
    • 12.15.4. RECENT DEVELOPMENTS

13. RELATED REPORTS

Back to Top